All In Biotech

Drug Trial Radar · NCT04501666

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis

Last checked: Nov 20, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 286 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

286

Actual

Start

Sep 11, 2020

Primary completion

Nov 11, 2022

Study completion Feb 21, 2023

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Aug 6, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective was to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (\>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.

Conditions

  • Prurigo Nodularis

Interventions

  • Nemolizumab 30 mgDrug

    Participants received either 30 mg or 60 mg dose of nemolizumab as SC injection.

  • PlaceboDrug

    Participants received matching placebo as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With an Improvement of Greater Than or Equal to (>=) 4 From Baseline in Weekly Average Peak Pruritus Numeric Rating Scale (PP NRS) at Week 16Time frame: Baseline, Week 16
  2. Number of Participants With an Investigator Global Assessment (IGA) Success at Week 16Time frame: Baseline, Week 16

Locations

100 sites in 10 countries. Site status is shown where the registry gives one.

  • Galderma Investigational Site

    Birmingham, Alabama

  • Galderma Investigational Site

    Birmingham, Alabama

  • Galderma Investigational Site

    Los Angeles, California

  • Galderma Investigational Site

    Sacramento, California

  • Galderma Investigational Site

    San Diego, California

  • Galderma Investigational Site

    San Diego, California

  • Galderma Investigational Site

    Santa Monica, California

  • Galderma Investigational Site

    Delray Beach, Florida

  • Galderma Investigational Site

    Hollywood, Florida

  • Galderma Investigational Site

    Largo, Florida

  • Galderma Investigational Site

    Miami, Florida

  • Galderma Investigational Site

    Pembroke Pines, Florida

  • Galderma Investigational Site

    Tampa, Florida

  • Galderma Investigational Site

    Columbus, Georgia

  • Galderma Investigational Site

    Macon, Georgia

  • Galderma Investigational Site

    Chicago, Illinois

  • Galderma Investigational Site

    Lake Bluff, Illinois

  • Galderma Investigational Site

    Topeka, Kansas

  • Galderma Investigational Site

    Baltimore, Maryland

  • Galderma Investigational Site

    Ann Arbor, Michigan

  • Galderma Investigational Site

    Saint Joseph, Missouri

  • Galderma Investigational Site

    St Louis, Missouri

  • Galderma Investigational Site

    New York, New York

  • Galderma Investigational Site

    High Point, North Carolina

  • Galderma Investigational Site

    Raleigh, North Carolina

  • Galderma Investigational Site

    Cleveland, Ohio

  • Galderma Investigational Site

    Norman, Oklahoma

  • Galderma Investigational Site

    Philadelphia, Pennsylvania

  • Galderma Investigational Site

    Philadelphia, Pennsylvania

  • Galderma Investigational Site

    Johnston, Rhode Island

  • Galderma Investigational Site

    Providence, Rhode Island

  • Galderma Investigational Site

    Knoxville, Tennessee

  • Galderma Investigational Site

    Austin, Texas

  • Galderma Investigational Site

    Bellaire, Texas

  • Galderma Investigational Site

    Laredo, Texas

  • Galderma Investigational Site

    Salt Lake City, Utah

  • Galderma Investigational Site

    Springville, Utah

  • Galderma Investigational Site

    Fairfax, Virginia

  • Galderma Investigational Site

    Graz, Austria

  • Galderma Investigational Site

    Linz, Austria

Showing 40 of 100 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.